Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob J de Haan

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Journal of Parkinson'S Disease|August 8, 2022
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's DiseaseConstant V M Verschuur, Sven R Suwijn, Rob J de Haan, et al.
Rheumatology (Oxford, England)|May 10, 2022
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot studyAnne W Walter, Johan Lim, Joost Raaphorst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2019
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extensionYasmine Emma Maria Dreissen, Joke M Dijk, Jeannette M Gelauff, et al.
Journal of Neurology|September 28, 2016
The frontotemporal syndrome of ALS is associated with poor survivalRosanne Govaarts, Emma Beeldman, Mike J Kampelmacher, et al.
The New England Journal of Medicine|January 24, 2019
Randomized Delayed-Start Trial of Levodopa in Parkinson's DiseaseConstant V M Verschuur, Sven R Suwijn, Judith A Boel, et al.
Neurology|September 14, 2012
The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALSJoost Raaphorst, Emma Beeldman, Ben Schmand, et al.
Neurology|October 17, 2022
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP StudyHenrieke L Frequin, Jason Schouten, Constant V M Verschuur, et al.
JAMA Neurology|May 19, 2020
Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical TrialJonathan M Coutinho, Susanna M Zuurbier, Marie-Germaine Bousser, et al.
Stroke|July 30, 2011
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient dataSanne M Zinkstok, Mervyn D I Vergouwen, Stefan T Engelter, et al.
Brain : a Journal of Neurology|February 9, 2022
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyMax E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Journal of Parkinson'S Disease|August 8, 2022
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's DiseaseConstant V M Verschuur, Sven R Suwijn, Rob J de Haan, et al.
Rheumatology (Oxford, England)|May 10, 2022
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot studyAnne W Walter, Johan Lim, Joost Raaphorst, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2019
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extensionYasmine Emma Maria Dreissen, Joke M Dijk, Jeannette M Gelauff, et al.
Journal of Neurology|September 28, 2016
The frontotemporal syndrome of ALS is associated with poor survivalRosanne Govaarts, Emma Beeldman, Mike J Kampelmacher, et al.
The New England Journal of Medicine|January 24, 2019
Randomized Delayed-Start Trial of Levodopa in Parkinson's DiseaseConstant V M Verschuur, Sven R Suwijn, Judith A Boel, et al.
Neurology|September 14, 2012
The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALSJoost Raaphorst, Emma Beeldman, Ben Schmand, et al.
Neurology|October 17, 2022
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP StudyHenrieke L Frequin, Jason Schouten, Constant V M Verschuur, et al.
JAMA Neurology|May 19, 2020
Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical TrialJonathan M Coutinho, Susanna M Zuurbier, Marie-Germaine Bousser, et al.
Stroke|July 30, 2011
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient dataSanne M Zinkstok, Mervyn D I Vergouwen, Stefan T Engelter, et al.
Brain : a Journal of Neurology|February 9, 2022
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyMax E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, et al.
Pageof 12